Sintx Technologies Inc (SINT)

$4.24 -0.35 (-7.63%)
Market Cap 15.20M
Revenue (ttm) 2.89M
Net Income (ttm) -11.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -381.31%
Debt to Equity Ratio 0.03
Volume 307,617
Avg Vol 972,678
Day's Range N/A - N/A
Shares Out 2.76M
Stochastic %K 33%
Beta 0.73
Analysts Sell
Price Target $28.00

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and polyetherketoneketone. The company was formerly known as Am...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 839 3500
Address:
1885 West 2100 South, Salt Lake City, United States
GluttonBoy
GluttonBoy Sep. 9 at 5:26 PM
TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play Watching these too : $GCTK $RDGT $IVF $GTI $SINT
0 · Reply
Boston7452
Boston7452 Sep. 9 at 3:10 PM
$SINT Nice to see the CSO building awarness
0 · Reply
Here4cabbage
Here4cabbage Sep. 9 at 2:03 PM
$SINT such an ugly chart lmao
0 · Reply
2TrustHim
2TrustHim Sep. 9 at 1:28 PM
$SINT When is Presentation?
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 9 at 1:20 PM
$NUWE coding this 4.31 for $SINT their special 4l31 *
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 9 at 1:08 PM
$NUWE brought metadata to u $SINT weaponizing the 4.42 anomaly $SLS
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 9 at 1:05 PM
$NUWE $SINT $BDRX $JAGX !
0 · Reply
Boston7452
Boston7452 Sep. 8 at 3:45 PM
$SINT
1 · Reply
MCAUL0898
MCAUL0898 Sep. 8 at 3:02 PM
$SINT And there we go - anybody who listened when I loaded at $4.30 got your reward back to the approx warrant price already. Only way is up!!!.
0 · Reply
Boston7452
Boston7452 Sep. 8 at 2:49 PM
$SINT The main problem here is very few people understand the immense value of Sintx IP. More importantly most people do not understand the good it can do for improving patient care and protecting those that care for them.
1 · Reply
Latest News on SINT
SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

Sep 8, 2025, 7:54 AM EDT - 1 day ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

Sep 8, 2025, 7:00 AM EDT - 1 day ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

Aug 15, 2025, 7:00 AM EDT - 25 days ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Aug 4, 2025, 7:00 AM EDT - 5 weeks ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

Jun 24, 2025, 8:30 AM EDT - 2 months ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 22, 2025, 7:00 AM EDT - 3 months ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025, 7:05 AM EDT - 4 months ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 26, 2025, 8:00 AM EST - 6 months ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Feb 20, 2025, 6:15 AM EST - 7 months ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Feb 19, 2025, 6:00 AM EST - 7 months ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Nov 21, 2024, 6:00 AM EST - 10 months ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Nov 19, 2024, 6:00 AM EST - 10 months ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

SINTX Technologies Announces Stock Repurchase Program

Nov 18, 2024, 6:00 AM EST - 10 months ago

SINTX Technologies Announces Stock Repurchase Program

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Nov 14, 2024, 6:00 AM EST - 10 months ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Oct 1, 2024, 8:00 AM EDT - 1 year ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Sep 9, 2024, 8:00 AM EDT - 1 year ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies to Explore Strategic Opportunities

Jun 18, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies to Explore Strategic Opportunities

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

Jun 12, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

Jun 6, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

May 23, 2024, 9:00 AM EDT - 1 year ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

Apr 29, 2024, 9:14 AM EDT - 1 year ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Apr 3, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

SINTX Technologies Announces Proposed Public Offering of Common Stock

Mar 29, 2024, 4:00 PM EDT - 1 year ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Mar 25, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)

Feb 23, 2024, 7:50 AM EST - 1 year ago

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)

GRI

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Feb 21, 2024, 9:00 AM EST - 1 year ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Feb 2, 2024, 2:33 PM EST - 1 year ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Jan 31, 2024, 9:20 AM EST - 1 year ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Jan 30, 2024, 4:01 PM EST - 1 year ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Jan 23, 2024, 9:00 AM EST - 1 year ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Jan 4, 2024, 9:00 AM EST - 1 year ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Nov 7, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

Nov 3, 2023, 8:28 AM EDT - 2 years ago

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

ARQT HSCS

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Oct 11, 2023, 9:00 AM EDT - 2 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

Aug 17, 2023, 9:00 AM EDT - 2 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

Feb 14, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

Feb 14, 2023, 9:00 AM EST - 2 years ago

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

SINTX Technologies Announces Closing of $12.0 Million Public Offering

Feb 10, 2023, 1:52 PM EST - 2 years ago

SINTX Technologies Announces Closing of $12.0 Million Public Offering

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

Feb 7, 2023, 9:05 PM EST - 2 years ago

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Jan 19, 2023, 9:00 AM EST - 2 years ago

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

Jan 6, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING

Dec 21, 2022, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE DECEMBER 20, 2022

Dec 19, 2022, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE DECEMBER 20, 2022

SINTX TECHNOLOGIES AWARDED MULTI-YEAR DARPA CONTRACT TO DEVELOP CMCs AND HIGH TEMPERATURE COATINGS FOR TURBINE ENGINES

Oct 26, 2022, 9:00 AM EDT - 3 years ago

SINTX TECHNOLOGIES AWARDED MULTI-YEAR DARPA CONTRACT TO DEVELOP CMCs AND HIGH TEMPERATURE COATINGS FOR TURBINE ENGINES

SINTX Technologies, Inc. Announces Subscriptions of Approximately $4.7 Million from its Rights Offering

Oct 13, 2022, 8:30 AM EDT - 3 years ago

SINTX Technologies, Inc. Announces Subscriptions of Approximately $4.7 Million from its Rights Offering

SINTX TECHNOLOGIES RECEIVES PRODUCTION ORDER FOR AEROSPACE COMPONENTS

Oct 11, 2022, 9:00 AM EDT - 3 years ago

SINTX TECHNOLOGIES RECEIVES PRODUCTION ORDER FOR AEROSPACE COMPONENTS

SINTX ANNOUNCES NEW ANTIBACTERIAL BIOMEDICAL PATENTS AND EXPANSION OF INTELLECTUAL PROPERTY PORTFOLIO

Oct 4, 2022, 11:05 AM EDT - 3 years ago

SINTX ANNOUNCES NEW ANTIBACTERIAL BIOMEDICAL PATENTS AND EXPANSION OF INTELLECTUAL PROPERTY PORTFOLIO

NATIONAL INSTITUTES OF HEALTH AWARDS GRANT TO SINTX TECHNOLOGIES FOR DEVELOPMENT OF 3D PRINTED ANTIMICROBIAL TRAUMA DEVICE

Sep 29, 2022, 9:00 AM EDT - 3 years ago

NATIONAL INSTITUTES OF HEALTH AWARDS GRANT TO SINTX TECHNOLOGIES FOR DEVELOPMENT OF 3D PRINTED ANTIMICROBIAL TRAUMA DEVICE

SINTX TECHNOLOGIES ANNOUNCES COMMENCEMENT OF RIGHTS OFFERING SUBSCRIPTION PERIOD AND UPDATED TERMS AND DATES OF ITS PREVIOUSLY ANNNOUNCED RIGHTS OFFERING

Sep 26, 2022, 9:00 AM EDT - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES COMMENCEMENT OF RIGHTS OFFERING SUBSCRIPTION PERIOD AND UPDATED TERMS AND DATES OF ITS PREVIOUSLY ANNNOUNCED RIGHTS OFFERING

GluttonBoy
GluttonBoy Sep. 9 at 5:26 PM
TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play Watching these too : $GCTK $RDGT $IVF $GTI $SINT
0 · Reply
Boston7452
Boston7452 Sep. 9 at 3:10 PM
$SINT Nice to see the CSO building awarness
0 · Reply
Here4cabbage
Here4cabbage Sep. 9 at 2:03 PM
$SINT such an ugly chart lmao
0 · Reply
2TrustHim
2TrustHim Sep. 9 at 1:28 PM
$SINT When is Presentation?
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 9 at 1:20 PM
$NUWE coding this 4.31 for $SINT their special 4l31 *
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 9 at 1:08 PM
$NUWE brought metadata to u $SINT weaponizing the 4.42 anomaly $SLS
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 9 at 1:05 PM
$NUWE $SINT $BDRX $JAGX !
0 · Reply
Boston7452
Boston7452 Sep. 8 at 3:45 PM
$SINT
1 · Reply
MCAUL0898
MCAUL0898 Sep. 8 at 3:02 PM
$SINT And there we go - anybody who listened when I loaded at $4.30 got your reward back to the approx warrant price already. Only way is up!!!.
0 · Reply
Boston7452
Boston7452 Sep. 8 at 2:49 PM
$SINT The main problem here is very few people understand the immense value of Sintx IP. More importantly most people do not understand the good it can do for improving patient care and protecting those that care for them.
1 · Reply
MCAUL0898
MCAUL0898 Sep. 8 at 2:39 PM
$SINT This would suggest that the price today at $4.30 is trading at a big discount, so expect $4.79 minimum this week.
0 · Reply
MCAUL0898
MCAUL0898 Sep. 8 at 2:38 PM
$SINT The warrants, originally issued in February 2025, carried an exercise price of $3.32 per share. In exchange for the immediate exercise, the company will issue new unregistered warrants to purchase up to 1,649,147 shares of common stock at an exercise price of $4.79 per share. The new warrants are exercisable immediately and expire five and one-half years after issuance.
0 · Reply
MCAUL0898
MCAUL0898 Sep. 8 at 2:32 PM
$SINT The warrants already were known so are not additional dilution. We talked about these last week that at some point they would do a takedown on those, but they have at least issued them at a higher price than the original prices which gives the company more money for the same quantity of shares to go and ramp up bringing this into profitable application and sales.
0 · Reply
km8
km8 Sep. 8 at 2:29 PM
$SINT Buy
0 · Reply
tommytwit
tommytwit Sep. 8 at 2:09 PM
$SINT I KNEW I should not have held it over the weekend....and yet I did......
0 · Reply
Boston7452
Boston7452 Sep. 8 at 1:55 PM
$SINT “We believe this is a defining moment for SINTX. This patent has the potential to elevate silicon nitride from a proven biomaterial into a true platform technology for infection prevention,”
2 · Reply
2TrustHim
2TrustHim Sep. 8 at 1:43 PM
$SINT this is a gift so you can buy
1 · Reply
Kcmule
Kcmule Sep. 8 at 1:32 PM
$SINT So they have successfully diluted shareholders. Again. Or is that still?
0 · Reply
Investerare_SAAB
Investerare_SAAB Sep. 8 at 1:26 PM
$SINT 2$ broooo
0 · Reply
Btolz
Btolz Sep. 8 at 1:22 PM
$SINT With the announcement of the patent why is this dropping? https://finance.yahoo.com/news/sintx-technologies-receives-uspto-notice-110000090.html
1 · Reply
victor275
victor275 Sep. 8 at 1:18 PM
$SINT till what price Will go down today can someone tell me, thanks
0 · Reply
LeveragedMarketAnalyst
LeveragedMarketAnalyst Sep. 8 at 1:17 PM
$SINT Insiders are buying and the company is expanding, this is good news! $NVDA $SOXL $AVGO
0 · Reply